Shlipak, M. G., Matsushita, K., Ärnlöv, J., Inker, L. A., Katz, R., Polkinghorne, K. R., . . . Gansevoort, R. T. (2013). Cystatin C versus Creatinine in Determining Risk Based on Kidney Function. The New England journal of medicine, 369(10), 932-943. https://doi.org/10.1056/NEJMoa1214234
Citace podle Chicago (17th ed.)Shlipak, Michael G., et al. "Cystatin C Versus Creatinine in Determining Risk Based on Kidney Function." The New England Journal of Medicine 369, no. 10 (2013): 932-943. https://doi.org/10.1056/NEJMoa1214234.
Citace podle MLA (9th ed.)Shlipak, Michael G., et al. "Cystatin C Versus Creatinine in Determining Risk Based on Kidney Function." The New England Journal of Medicine, vol. 369, no. 10, 2013, pp. 932-943, https://doi.org/10.1056/NEJMoa1214234.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..